SCN5A and arrhythmogenic right ventricular cardiomyopathy: In ARVC, fibrofatty replacement of myocardium disrupts electrical conduction by impairing cell-to-cell coupling, reducing connexin-43 expression, and slowing conduction through decreased Nav1.5 channels [9].